Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+/HER2- Breast Cancer

Download video

Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+/HER2- Breast Cancer

6 views

Physicians' Education Resource

2 months ago

Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+/HER2- Breast Cancer

$Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+\/HER2- Breast Cancer$

1:05

Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+\/HER2- Breast Cancer

by Physicians' Education Resource

4:30

HER2-Targeted TKI Combinations in Second-Line and Beyond MBC

by ReachMD

8:52

HER2 Positive Breast Cancer: What You Need to Know

by Cancer Treatment Updates

$ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+\/HER2- early breast cancer$

1:41

ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+\/HER2- early breast cancer

by VJOncology

1:39:35

HER2-Positive, Triple-Negative and Localized Breast Cancer - @ 4th Annual National GMO Summit

by Research To Practice

4:29

Next generation CDK4 + CDK2 selective inhibitor in HR+ HER2- metastatic breast cancer

by VJOncology

19:21

كل ما يتعلق بتحليل الصبغات المناعية HER2 وماذا تعنى نتائجه المختلفه وما الفرق بين الايجابى و السلبي

by حارب السرطان مع دكتور محمد الجزار Fight Cancer

8:26

Breast Cancer Receptors: Learn What You Need to Know

by Breast Cancer School for Patients

5:15

Triple Positive Breast Cancer: Treatment Options Explained

by Yerbba – Breast Cancer

2:36

HER 2 + (positive) Breast Cancer

by Biotech Primer

2:01

Reducing Overtreatment With Smarter Breast Cancer Therapies – Dr. Simone Nardin

by MD Newsline

6:12

Next-Generation Sequencing in HER2+ Breast Cancer

by Targeted Oncology

1:53:20

44- HER2 Positive Disease

by iBreastBook

$MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape$

1:00:45

MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape

by Susan G. Komen®

$Optimisation of Treatment Selection \& Sequencing Decisions in ER+\/HER2- Breast Cancer$

14:24

Optimisation of Treatment Selection \& Sequencing Decisions in ER+\/HER2- Breast Cancer

by COR2ED The Heart of Medical Education

$Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer$

1:20

Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer

by VJOncology

2:43

Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference

by Total Health | Oncology

1:47

HER2+ Breast Cancer: What It Is and How It’s Treated | GoodRx

by GoodRx

Best on Vidoe

Next-Generation Endocrine Targeting Therapies to Improve Outcomes in HR+/HER2- Breast Cancer